Researching cancer growth to stop it in its tracks
A key focus of UWA’s cancer research division is precision medicine to improve the prevention, diagnosis and treatment of this disease. We have a number of blood based diagnostic projects aimed at improving the detection and monitoring of cancer. Our current areas of interest include circulating tumour cells, tumour educated platelets, cell free DNA and tumour derived exosome detection for both solid tumours and haematological malignancies. We have a range of additional projects detailed below.
All of our studies involve collaborations with clinicians, industry and the community to enable new findings that are clinically relevant and will make a difference to those with cancer. We research a broad range of cancer types, including haematological malignancies (adult and paediatric myeloproliferative neoplasms, CLL, AML, ALL, myeloma, myelodysplastic syndromes), carcinomas of unknown primary, breast cancer, head and neck cancer, melanoma, colorectal cancer, glioblastoma, oesophageal adenocarcinoma and others.
Translational Cancer Pathology Laboratory
Research in this lab focuses on haematological malignancies, breast cancer and carcinoma of unknown primary. Our work aims to create a ‘precision’ pathology, or a unique cancer fingerprint, allowing for personalised therapy. Through our research, we hope to transform cancer pathology testing and offer improved cancer patient care throughout Australia and the world.
Translational cancer pathology is the application of new scientific discoveries to diagnostic pathology of malignant diseases. This combines molecular and cellular research to develop diagnostic tools which results in new therapeutic approaches. Translational cancer pathology strives to bridge the gap between pure science and patient care.
We have a diverse range of research and projects described below. We encourage all interested domestic and international students to review these projects and contact the Graduate Research Coordinator on email@example.com to discuss any of these in more detail.
School of Biomedical Sciences
UWA’s School of Biomedical Sciences encompasses teaching and research in a range of biological, medical and health-related fields. Our range of undergraduate and postgraduate courses give students the opportunity to gain a greater understanding of the intersection between human pathology and health, and an awareness of the approaches and applications of the biomedical scientific disciplines.
Meet Professor Wendy Erber, Cancer Researcher of the Year
Professor Wendy Erber sat down with 6PR Morning's Gary Adshead and gave him an insight into the work she does and why it makes her something of a ‘Sherlock Holmes’.Read more
J. Robin Warren LibraryLibrary
Professor (John) Robin Warren was a co-recipient, with Professor Barry J Marshall, of the Nobel Prize for Medicine in 2005 for their discovery that stomach ulcers were caused by the bacteria Helicobacter pylori.Read more about J. Robin Warren Library
Biomedical Sciences E-Learning Suites
The interactive suites offer students practical diagnostic experience and an environment that mimics the consultative nature of a working laboratory.Read more about Biomedical Sciences E-Learning Suites
CTEC combines an interactive hospital environment with expert clinical educators to offer training to junior doctors and senior consultants in a way that supplements traditional clinical-based training.Read more about CTEC
Our unique collection is used to educate medical, nursing and science undergraduates, and assists in training specialist pathologists to improve their understanding of mechanisms of disease and diagnostic pathology.Read more about Pathology museum
UWA Health Campus
The UWA Health Campus provides cutting-edge specialist teaching and learning facilities for students, professionals and patients.Read more about UWA Health Campus
2018 IQ Awards celebrate new inventions improving the world
Professor Wendy Erber, Dr Kathy Fuller and PhD student Henry Hui from UWA’s Faculty of Health and Medical Sciences won the Research Innovation and Enterprise Award for developing Immuno-flowFISH, a device that will significantly improve the ability to identify genetic changes in leukaemia cancer cells.Read more